why choose us

Clinical Trials Search

Showing 7,820 of 132,085 result(s)
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Status: Completed

Condition: Breast Cancer

Interventions: Participants will choose from one of three 20-minute prerecorded hypnosis audio files.
Practices using the recordings will be documented on the h

Date: 2023-09-19

IC-8 Apthera IOL New Enrollment Post Approval Study

Status: Completed

Condition: Cataract

Interventions:

Date: 2023-09-19

Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment

Status: NOT_YET_RECRUITING

Condition: Opioid Use Disorder

Interventions: The PIPR is measured in six, 80-s test periods in which the stimulus, either Blue (470 nm) or Red (623 nm), is presented to the dilated eye while the

Date: 2023-09-19

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Status: NOT_YET_RECRUITING

Condition: Demyelinating Diseases

Interventions: 12 or 8 mg Clemastine tablet.
Clemastine fumarate was approved by the Food and Drug Administration (FDA) for the treatment of allergic rhinitis (

Date: 2023-09-19

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Status: Completed

Condition: Solid Tumor, KRAS Mutation

Interventions: BI 3706674

Date: 2023-09-19

K01 Impacts of Lingual Endurance Exercise

Status: Completed

Condition: Dysphagia

Interventions: Pressing tongue against a pressure sensor at the set number of repetitions per session (individualized per participant) 3 times per day

Date: 2023-09-19

Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience

Status: Completed

Condition: Safety

Interventions: Single administration thirty minutes after the start of a high-fat breakfast

Date: 2023-09-19

The Weight of Cardiovascular Disease

Status: NOT_YET_RECRUITING

Condition: Cardiovascular Diseases

Interventions:

Date: 2023-09-19

Biomarkers to Detect Endocrine Therapy Resistance

Status: Completed

Condition: Metastatic Cancer

Interventions: The dose of the investigational imaging agent, FFNP, is approximately 7 millicurie (mCi) (259 megabecquerels (MBq)), IV slow infusion over approximate

Date: 2023-09-19

CGM and DFU Healing Post-discharge

Status: NOT_YET_RECRUITING

Condition: Diabetic Foot

Interventions: Participants randomized to rt-CGM will have CGM placed prior to hospital discharge.
They will also receive teaching from the research team on the

Date: 2023-09-19